A pilot study of gemcitabine, nab-paclitaxel, PEGPH20 (PAG) and rivaroxaban for advanced pancreatic adenocarcinoma: Interim safety and efficacy analysis
Yu, K., Mantha, S., Tjan, C., Kaufmann, E., Brenner, R.B., Lowery, M., Ku, G., Raj, N., Shcherba, M., Goldberg, Z., Li, J., Zervoudakis, A., Hamilton, A., Won, E., Do, R.K.G., O’Reilly, E.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article